Therapeutic effects of fermented soycrud on phenotypes of atopic dermatitis induced by phthalic anhydride.
10.5625/lar.2013.29.2.103
- Author:
Ji Eun SUNG
1
;
Moon Hwa KWAK
;
Ji Eun KIM
;
Young Ju LEE
;
Ro Ui KIM
;
Eun Ah KIM
;
Ga Young LEE
;
Dong Seob KIM
;
Dae Youn HWANG
Author Information
1. Department of Biomaterials Science, College of Natural Resources & Life Science, Pusan National University, Miryang, Korea. dyhwang@pusan.ac.kr
- Publication Type:Original Article
- Keywords:
Atopic dermatitis;
soycrud;
phthalic anhydride;
ear thickness;
mast cells
- MeSH:
Animals;
Body Weight;
Cell Count;
Dermatitis, Atopic;
Ear;
Enzyme-Linked Immunosorbent Assay;
Histamine;
Hypersensitivity;
Immunoglobulin E;
Lymph Nodes;
Mast Cells;
Mice;
Mice, Inbred ICR;
Microwaves;
Organ Size;
Phenotype;
Phthalic Anhydrides;
Skin Diseases;
Soy Foods;
Spleen;
Thymus Gland;
Water;
Weights and Measures
- From:Laboratory Animal Research
2013;29(2):103-112
- CountryRepublic of Korea
- Language:English
-
Abstract:
Atopic dermatitis (AD), which is known as the most common pruritic skin disease, is caused by epidermal barrier dysfunction, allergies, microwave radiation, histamine intolerance, and genetic defects. To investigate the therapeutic effects of fermented soycrud (FSC) on AD pathology, alteration of AD phenotypes induced by phthalic anhydride (PA) treatment was assessed by ear thickness analysis, measurement of immune-related organ weights, ELISA, and histological and pathological analyses of ICR mice after FSC treatment for 2 weeks. Except for water content, the concentrations of most major components were lower in FSC compared to common tofu (CMT). Thymus and lymph node weights were significantly reduced in ICR mice treated with PA+CMT or PA+FSC, whereas spleen and body weights were maintained. Elevation of ear thickness induced by PA treatment was rapidly diminished in the CMT- and FSC-treated groups, although there was no significant difference between the two groups. Furthermore, significant reduction of epidermal thickness was detected in both the PA+CMT- and PA+FSC-treated groups. However, IgE concentration and dermal thickness were reduced only by PA+FSC treatment, whereas PA+CMT treatment maintained levels comparable to PA+vehicle treatment. The number of infiltrated mast cells was higher in the PA+vehicle-treated group compared to the untreated control. Following CMT or FSC treatment, mast cell infiltration was slightly reduced, although the CMT-treated group showed greater cell numbers. These results indicate that FSC may significantly relieve the phenotypes of AD induced by PA treatment and should be considered as a potential candidate for AD therapy.
